HC Wainwright cuts Sinovac Biotech price target to $1.00
HC Wainwright & Co. cut its price target for Sinovac Biotech to $1.00 per share from $6.00,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.